Anticonvulsant activity of perampanel, a selective AMPA receptor antagonist, in rodent models of epileptic seizure

被引：0
|
作者：
Hashizume, Y. [1 ]
Hanada, T. [1 ]
Ogasawara, A. [1 ]
Ueno, M. [1 ]
Nishizawa, Y. [1 ]
机构：
[1] Eisai Tsukuba Res Labs, Tsukuba, Ibaraki, Japan
来源：
JOURNAL OF NEUROLOGY | 2008年 / 255卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O133
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [41] Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models
    Gigler, G.
    Moricz, K.
    Agoston, M.
    Simo, A.
    Albert, M.
    Benedek, A.
    Kapus, G.
    Kertesz, S.
    Vegh, M.
    Barkoczy, J.
    Marko, B.
    Szabo, G.
    Matucz, E.
    Gacsalyi, I.
    Levay, G.
    Harsing, L. G., Jr.
    Szenasi, G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (01) : 151 - 160
  • [42] Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam
    Borowicz, KK
    Luszczki, J
    Szadkowski, M
    Kleinrok, Z
    Czuczwar, SJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 380 (2-3) : 67 - 72
  • [43] Global Phase III Trials of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures
    French, Jacqueline
    Elger, Christian
    Goldberg-Stern, Hadassa
    Thomson, Alfredo
    Krauss, Gregory L.
    Squillacote, David
    Yang, Haichen
    Kumar, Dinesh
    NEUROLOGY, 2011, 76 (09) : A376 - A376
  • [44] PHARMACOKINETICS OF PERAMPANEL, A HIGHLY SELECTIVE AMPA-TYPE GLUTAMATE RECEPTOR ANTAGONIST FOLLOWING ONCE- AND MULTIPLE-DAILY DOSING
    Templeton, D.
    EPILEPSIA, 2010, 51 : 70 - 70
  • [45] PHASE III EVALUATION OF PERAMPANEL, A SELECTIVE, NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY FOR REFRACTORY PARTIAL-ONSET SEIZURES: EFFECTS ON SEIZURE FREEDOM AND OTHER EXPLORATORY EFFICACY END POINTS
    Steinhoff, B. J.
    French, J.
    Kwan, P.
    Yang, H.
    Squillacote, D.
    Zhu, J.
    Laurenza, A.
    EPILEPSIA, 2011, 52 : 254 - 254
  • [46] The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia
    Erdö, F
    Berzenyi, P
    Andrási, F
    BRAIN RESEARCH BULLETIN, 2005, 66 (01) : 43 - 49
  • [47] Animal Models for Human Seizure and Epileptic Activity Reply
    Sarkisian, Matthew R.
    EPILEPSY & BEHAVIOR, 2001, 2 (05) : 506 - 507
  • [48] ONE-YEAR EXPERIENCE WITH NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST PERAMPANEL - FOCUS ON PSYCHIATRIC ADVERSE EFFECTS
    Volna, K.
    Krijtova, H.
    Tomasek, M.
    Elisak, M.
    Fabera, P.
    Kalina, A.
    Martinkovic, L.
    Sulc, V
    Zarubova, J.
    Marusic, P.
    EPILEPSIA, 2016, 57 : 227 - 227
  • [49] Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures
    Rektor, Ivan
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 225 - 235
  • [50] Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists
    De Sarro, G
    Ferreri, G
    Russo, E
    Gitto, R
    Barreca, ML
    Chimirri, A
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136
12345